The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo

Author：

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.30, Iss.5, 2012-01, pp. : 1087-1094

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corosolic Acid Exhibits Anti‐angiogenic and Anti‐lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT‐26 Colon Carcinoma Animal Model

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 5, 2015-05 ,pp. : 714-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 242-249

Karger

Access to resources Recommend Favorite

Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo

International Journal of Molecular Medicine, Vol. 30, Iss. 2, 2012-01 ,pp. : 358-364

Spandidos Publications

Access to resources Recommend Favorite

Antioxidant activity and inhibition effect on the growth of human colon carcinoma (HT-29) cells of esculetin from Cortex Fraxini

By Wang Kai

Medicinal Chemistry Research, Vol. 20, Iss. 7, 2011-09 ,pp. : 968-974

Springer Publishing Company

Access to resources Recommend Favorite

Low-Dose Buspirone, Melatonin and Low-Dose Bupropion Added to Mood Stabilizers for Severe Treatment-Resistant Bipolar Depression

Psychotherapy and Psychosomatics, Vol. 78, Iss. 6, 2009-09 ,pp. : 391-393

Karger

Access to resources Recommend Favorite